1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Evaluation of aneurysm occlusion status with different imaging modalities
DSA κ (95% CI) InCO CO Total TOF-MRA 0.794 (0.579–1.0) InCO 12 0 12 CO 3 14 17 Total 15 14 29 HR-VW-MR imaging 0.525 (0.255–0.794) InCO 8 0 8 CO 7 14 21 Total 15 14 29 TOF-MRA combined with HR-VW-MR imaging 0.931 (0.799–1.0) InCO 14 0 14 CO 1 14 15 Total 15 14 29
Note:—CO indicates complete occlusion; InCO, incomplete occlusion.